Source comparison
Can You Stack MOTS-c 5-Amino-1MQ: Metabolic Pathway Comparison
The table below compares MOTS-c and 5-Amino-1MQ across mechanism, target tissue, administration, and expected timeline. Demonstrating why their combination is mechanistically sound. Primary Mechanism AMPK activation → fat oxidation, insulin sensitivity NNMT in
This comparison does not assign a generated winner or score.
- The table below compares MOTS-c and 5-Amino-1MQ across mechanism, target tissue, administration, and expected timeline. Demonstrating why their combination is mechanistically sound.
- Primary Mechanism
- AMPK activation → fat oxidation, insulin sensitivity
- NNMT inhibition → NAD+ preservation, mitochondrial support
- Non-overlapping pathways. One signals, one preserves cofactor availability
- Molecular Target
- AMPK enzyme, nuclear gene transcription
- NNMT enzyme in adipose tissue
- No receptor competition or enzymatic conflict
- Target Tissue
- Skeletal muscle, liver, adipose tissue
- Primarily adipose tissue, liver
- Complementary tissue distribution with some overlap for enhanced effect
- Administration Route
- Subcutaneous injection (reconstituted peptide)
- Oral or subcutaneous (small molecule)
- Different administration requirements. No formulation conflict
- Typical Dosing (Research)
- 5–15 mg/kg subcutaneous, daily or alternate days
- 25–50 mg/kg oral or subcutaneous, daily
- Dosing schedules align for concurrent administration
- Half-Life
- 2–4 hours (effects persist 12–24 hours via AMPK phosphorylation)
- 4–6 hours (NNMT inhibition sustained with daily dosing)
- Short half-lives require consistent dosing but don't cause accumulation risk
- Onset of Metabolic Effect
- AMPK activation within hours; measurable metabolic changes in 7–10 days
- NAD+ increases within 10 days; fat mass reduction in 14–21 days
- Timelines overlap. Synergistic effects observable within 14–21 days of stacking
- Storage Requirements
- Lyophilised: −20°C; reconstituted: 2–8°C, use within 28 days
- Room temperature stable in capsule form
- No logistical conflict in storage or handling
- Stacking Compatibility
- Compatible with growth hormone secretagogues, NAD+ precursors
- Compatible with AMPK activators, mitochondrial support compounds
- Mechanistic analysis confirms no pharmacological antagonism when you stack MOTS-c 5-Amino-1MQ